Qsemble Capital Management, LP
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1766159
New York, NY
Position in ARWR
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$459,634
New position
Shares Held
5,639
first reported quarter
Ownership
0.004%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#302
of 497 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qsemble Capital Management, LP holds $7,848,553 across 6 Biotechnology names. ARWR ranks #5 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
31,633 | $2,356,025 | |
| 2 | INSM |
INSMED Inc
|
21,148 | $2,254,799 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
47,971 | $1,871,348 | |
| 4 | RPRX |
Royalty Pharma plc
|
10,675 | $598,547 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
This page
|
5,639 | $459,634 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
3,887 | $308,200 |
All Filings in ARWR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $459,634 | 5,639 | Shares | Sole | 2026-08-03 | |
| No filing history on record for this holder in this stock. | ||||||